Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PHCC Priority Healthcare -- Ignore unavailable to you. Want to Upgrade?

To: Sir Auric Goldfinger who wrote (63)	3/30/2001 12:50:21 PM
From: afrayem onigwecher	Read Replies (1) \| Respond to of 103

Trading Data Monthly Share Vol. Mkt. & Extd. Hrs. Extd. Hrs. Only --------------------------- Nasdaq Day One Extd. Hrs. Report MP Position Report Market Activity Nasdaq-100 Index Financial-100 Biotech Index Short Interest Nasdaq Monthly Short Interest Nasdaq® short interest is available by issue for a rolling twelve months and is based on a mid-month settlement date. The short interest report is also available in a comma-delimited text file (.txt). View Short Interest Step 1 Enter an Issue Symbol Step 2 Select a Month Mar 2001 Feb 2001 Jan 2001 Dec 2000 Nov 2000 Oct 2000 Sep 2000 Aug 2000 Jul 2000 Jun 2000 May 2000 Apr 2000 -------------------------------------------------------------------------------- March 2001 Short Interest Percent Change Average Daily Share Volume Days to Cover PHCC Priority Healthcare Corporation - Class B Common Stock 842,163 21.94 624,721 1.35 nasdaqtrader.com

To: Sir Auric Goldfinger who wrote (63)	7/3/2001 12:24:10 PM
From: Sir Auric Goldfinger	Respond to of 103

Yes Isaac, like all of the pigs you fondle, it is just a matter of time: "Priority Healthcare Falls on Lower 2nd-Qtr Estimate 2001-07-02 16:22 (New York) Lake Mary, Florida, July 2 (Bloomberg) -- Shares of Priority Healthcare Corp. fell 15 percent after the specialty pharmacy and drug distributor said second-quarter earnings were lower than estimated, partly because of product delays and lower interest income. The shares fell $4.14 to $24.14. Before today, Priority had dropped 31 percent this year. Profit was 4 cents to 6 cents a share less than the consensus forecast, the company said on a conference call. The company had been expected to earn 22 cents a share, the average estimate of analysts surveyed by First Call/Thomson Financial. Chief Executive Robert Myers, who didn't take questions on the call, said the six interest-rate reductions by the Federal Reserve this year reduced interest income by about $1 million, or ``roughly 1 cent to a cent and a half.'' Priority Healthcare provides pharmaceutical services for patients with chronic diseases or genetic disorders that require complex therapy. The Lake Mary, Florida-based company will report second-quarter results on July 19. Changes in the way insurers reimbursed Priority also affected the results as `` more products are being reimbursed out of pharmacy benefit managers instead of major medical benefits,'' bringing in lower fees, First Union Securities Inc. analyst Seth Teich said. He said the company's stock price reflects the news and raised his rating on the stock to ``strong buy'' from ``buy'' today. Merrill Lynch cut its intermediate-term rating on the stock to ``neutral'' from ``accumulate.'' Priority said it is taking charges for the quarter related to an investment in closely held software maker Cytura Corp. and expenses related to the acquisitions of infertility pharmacy Freedom Drug and biopharmaceutical distributor Physicians Formulary International Inc. The company also expects to take charges related to recently announced partnerships and bad debt. These charges are likely to further reduce earnings ``by a significant amount,'' Myers said in the statement. (Priority Healthcare's conference call can be accessed at the investor relations page on the Web site, priorityhealthcare.com) --Ambre Brown Morley in the Princeton newsroom (609) 279-4016, or at amorley1@bloomberg.net, with reporting by Bob Kuzbyt in Princeton/pas/ tab/jcn Story illustration: To graph the performance of the company's shares, see {PHCC US <Equity> TRA D <GO>}.